A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
Monine M, Norris D, Wang Y, Nestorov I.
J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):639-654. doi: 10.1007/s10928-021-09761-0. Epub 2021 May 15.
Temporal pathway analysis of cerebrospinal fluid proteome in herpes simplex encephalitis.
Nääs A, Li P, Ahlm C, Aurelius E, Järhult JD, Schliamser S, Studahl M, Xiao W, Bergquist J, Westman G.
Infect Dis (Lond). 2023 Oct;55(10):694-705. doi: 10.1080/23744235.2023.2230281. Epub 2023 Jul 3.
Mass spectrometric analysis of cerebrospinal fluid protein for glioma and its clinical application.
Liu J, Yu J, Shen H, Zhang J, Liu W, Chen Z, He S, Zheng S.
Contemp Oncol (Pozn). 2014;18(2):100-5. doi: 10.5114/wo.2014.40455. Epub 2014 Jun 3.
Semi-quantitative analysis of serum and cerebrospinal fluid transferrin glycoforms by top-down liquid chromatography mass spectrometry.
Kam RKT, Cheng JYK, Subramaniam SR, Kwok JSS.
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Oct 15;1247:124306. doi: 10.1016/j.jchromb.2024.124306. Epub 2024 Sep 12.
Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid Using (18)O Labeling.
Birke R, Krause E, Schümann M, Blasig IE, Haseloff RF.
Methods Mol Biol. 2019;2044:119-128. doi: 10.1007/978-1-4939-9706-0_8.
Discrepancies between qualitative and quantitative analysis of cerebrospinal fluid IgG: densitometric comparison of nephelometry-silver versus immuno-enzymes.
Keir G, Barrio S, Thompson EJ.
Ann Clin Biochem. 2008 Jul;45(Pt 4):404-8. doi: 10.1258/acb.2008.007056.
Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
Martin SJ, McGlasson S, Hunt D, Overell J.
J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1059-1067. doi: 10.1136/jnnp-2018-319190. Epub 2019 May 23.
Intelligent Identification of Cerebrospinal Fluid for the Diagnosis of Parkinson's Disease.
Chen H, Guo S, Zhuang Z, Ouyang S, Lin P, Zheng Z, You Y, Zhou X, Li Y, Lu J, Liu N, Tao J, Long H, Zhao P.
Anal Chem. 2024 Feb 13;96(6):2534-2542. doi: 10.1021/acs.analchem.3c04849. Epub 2024 Feb 1.
Time-Dependent Changes in the Biofluid Levels of Neural Injury Markers in Severe Traumatic Brain Injury Patients-Cerebrospinal Fluid and Cerebral Microdialysates: A Longitudinal Prospective Pilot Study.
Lin IH, Kamnaksh A, Aniceto R, McCullough J, Bekdash R, Eklund M, Ghatan PH, Risling M, Svensson M, Bellander BM, Nelson DW, Thelin EP, Agoston DV.
Neurotrauma Rep. 2023 Mar 1;4(1):107-117. doi: 10.1089/neur.2022.0076. eCollection 2023.
The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis.
Gigase FAJ, Smith E, Collins B, Moore K, Snijders GJLJ, Katz D, Bergink V, Perez-Rodriquez MM, De Witte LD.
Mol Psychiatry. 2023 Apr;28(4):1502-1515. doi: 10.1038/s41380-023-01976-6. Epub 2023 Apr 13.
